ClosedPublished 22 Jan 2025

Exicure Inc. /
GPCR Therapeutics USA Inc.

Exicure purchases GPCR Therapeutics USA in share transaction

Buy side: Exicure Inc.
Buy sideExicure Inc.
Target: GPCR Therapeutics USA Inc.
TargetGPCR Therapeutics USA Inc.
Source · 22 Jan 2025Source-verified
Buy side: Exicure Inc.
Buy sideExicure Inc.
Target: GPCR Therapeutics USA Inc.
TargetGPCR Therapeutics USA Inc.
01 / BuyerExicure Inc.
02 / TargetGPCR Therapeutics USA Inc.
Source-verified
01

What happened

Exicure Inc. purchased all of the issued and outstanding equity securities of GPCR Therapeutics USA Inc. from GPCR Therapeutics Inc. The transaction closed concurrently with execution of the Share Purchase Agreement.

Exicure purchased six million shares outstanding at approximately $0.27 per share million.

02

The source

Everything on this page comes from the source below.

01
Source · Original source

Exicure purchases GPCR Therapeutics USA in share transaction

This document is the source for the companies, stage, figure and people on this page.

Source-verified
03

Timeline

Every date the source states, in order. Anything marked ahead is a target the source gives, not something that has happened.

  1. Published by the source

    The source this page is built from.

    Source-verified

The same firms, in other deals

The firms' deal history and connections across other deals.

These firms' full profiles are part of Pro.

Request an inviteAlready invited? Sign in

Carrywatch Pro is by invitation. An invite lets you buy Pro.